Chester County News and Community Website
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced a significant advancement in its ongoing clinical trial for Stargardt disease. The Data Safety and Monitoring Board (DSMB) for the …
Ocugen’s OCU410ST Advances in Clinical Trial for Stargardt Disease, Moving to Medium Dose Testing Read More
DOYLESTOWN, PA — In a significant stride toward advancing cancer treatment, Antennova, a clinical-stage biotechnology firm dedicated to oncology, has announced the successful completion of the first dosing cohort in …
Antennova Marks Milestone in Cancer Treatment with Promising Early Results from Anti-CD24 Antibody Trial Read More
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS), a biotech firm focused on developing novel treatments for neurodegenerative diseases, announced the successful completion of data cleaning for its pivotal phase …
Annovis Bio Nears Milestone in Alzheimer’s Treatment Study with Completion of Data Cleaning Read More
PHILADELPHIA, PA — Clario, a titan in clinical trial management, has joined forces with the esteemed Cole Eye Institute at Cleveland Clinic. This partnership is poised to revolutionize the landscape …
Clario and Cleveland Clinic Forge Path in Ophthalmology Trials with AI-Powered Partnership Read More
SPRING HOUSE, PA — Johnson & Johnson announced it recently submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for TREMFYA® (guselkumab). This application …
Johnson & Johnson Seeks FDA Approval for New Ulcerative Colitis Treatment Read More MALVERN, PA — Ophthalmology is on the crest of a wave; a paradigm shift heralded by Ocugen, Inc (NASDAQ: OCGN) may be imminent. The Pennsylvania-based biopharmaceutical firm recently crossed a …
Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon Read More
NEWTOWN, PA — Helius Medical Technologies, Inc., a pioneering neurotech firm, has recently launched an open-label study aimed at improving the lives of chronic stroke survivors. The study is part …
Helius Advances Stroke Therapy with Groundbreaking Open-Label Study Read More
BALA CYNWYD, PA — Clinical-stage biotechnology company Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced the dosing of the first patient in an open label extension (OLE) study for its novel …
Larimar Therapeutics Advances Nomlabofusp Clinical Program with First Patient Dosed in Open Label Extension Study Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company, recently reported an increase in both research and development (R&D) and general administrative expenses for the fourth quarter and …
Savara Inc. Reports Increased Expenses, Anticipates Positive Data from IMPALA-2 Trial Read More
RADNR, PA — Marinus Pharmaceuticals, a leading biopharmaceutical company, reported impressive growth and financial performance for the fourth quarter and also for the year ending December 31, 2023, making a …
Marinus Pharmaceuticals Excels in Q4 Financial Results Aligning with Successful Clinical Trials and Product Performance Read More